EuroCTO: What is the best option for treating CTO: PCI or optimal medical therapy?


Which approach best improves clinical symptoms? Join G. Werner as he reviews this randomized trial whose goal was the assessment of these two strategies and their impact on the overall health of patients at 12 months. Learn of the specificities of this trial including how patients with multivessel disease were included in both arms, as well as the efficacy of either treatment or the number of crossovers after intention-to-treat was decided upon. Finally, which approach proved to be more successful in improving angina frequency or quality of life? Learn more here.